A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

Living with diabetes requires proactive lifestyle management. A balanced diet, regular exercise, and avoiding alcohol and ...

Fetch faculty members offer unique insights about behavior associated with diabetes, diabetic ketoacidosis, and new drug ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

November is Diabetes awareness month. Diabetes (Diabetes mellitus) is a common endocrine disorder in all mammals, dogs and cats included. Diabetes is characterized by a dysfunction of insulin ...

Type 2 Diabetes, In Vivo Model, High-Voltage Electrotherapy, Glucose Tolerance Test (GTT), Hematological Analysis Kriman, V. (2024) Study of the Effect of High-Voltage Low-Frequency Electrotherapy on ...

Diabetes and obesity are intertwined health conditions with serious consequences if left unmanaged. Obesity increases the ...